477 related articles for article (PubMed ID: 26845702)
1. Posterior Reversible Encephalopathy Syndrome Associated with Sorafenib and Successful Retreatment.
Laruelle M; Filleul B; Duprez T; Machiels JP
Urol Int; 2018; 100(3):357-360. PubMed ID: 26845702
[TBL] [Abstract][Full Text] [Related]
2. Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma.
Asaithambi G; Peters BR; Hurliman E; Moran BP; Khan AS; Taylor RA
J Clin Pharm Ther; 2013 Apr; 38(2):175-6. PubMed ID: 23210935
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced posterior reversible encephalopathy syndrome.
Prescrire Int; 2017 Apr; 26(181):98-101. PubMed ID: 30730661
[TBL] [Abstract][Full Text] [Related]
4. Childhood posterior reversible encephalopathy syndrome: Magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal.
Agarwal A; Kapur G; Altinok D
Neuroradiol J; 2015 Dec; 28(6):638-43. PubMed ID: 26515749
[TBL] [Abstract][Full Text] [Related]
5. [PRES (Posterior Reversible Encephalopathy Syndrome): potential complication of hypertensive crisis. Case report and literature review].
Vergura M; Prencipe M; Del Giudice AM; Grifa R; Miscio F; Pennelli AM; Popolizio T; Simeone A; Ferrara M; Leone M; Aucella F
G Ital Nefrol; 2017 Apr; 34(2):100-109. PubMed ID: 28682567
[TBL] [Abstract][Full Text] [Related]
6. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome following a scorpion sting.
Porcello Marrone LC; Marrone BF; Neto FK; Costa FC; Thomé GG; Aramburu MB; Schilling LP; Pascoal TA; Gadonski G; Huf Marrone AC; da Costa JC
J Neuroimaging; 2013 Oct; 23(4):535-6. PubMed ID: 23551823
[TBL] [Abstract][Full Text] [Related]
8. [Posterior reversible encephalopathy syndrome].
Petrović B; Kostić V; Sternić N; Kolar J; Tasić N
Srp Arh Celok Lek; 2003; 131(11-12):461-6. PubMed ID: 15114789
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: a case report and literature review.
Nakamura Y; Sugino M; Tsukahara A; Nakazawa H; Yamamoto N; Arawaka S
BMC Neurol; 2018 Nov; 18(1):190. PubMed ID: 30419835
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia.
Tavil B; Isgandarova F; Bayhan T; Unal S; Kuskonmaz B; Gumruk F; Cetin M
J Pediatr Hematol Oncol; 2016 Apr; 38(3):240-2. PubMed ID: 26907662
[TBL] [Abstract][Full Text] [Related]
11. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.
Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K
Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome in the Intensive Care Unit after liver transplant: a comparison of our experience with the existing literature.
Lunardi N; Saraceni E; Boccagni P; Segato M; Bortolato A; Manara R; Rossi S; Ori C
Minerva Anestesiol; 2012 Jul; 78(7):847-50. PubMed ID: 21701444
[TBL] [Abstract][Full Text] [Related]
13. Posterior reversible encephalopathy syndrome: a case study.
Wright KL; Polito MH; French AE
Am J Nurs; 2012 May; 112(5):36-40; quiz 41-2. PubMed ID: 22546734
[TBL] [Abstract][Full Text] [Related]
14. Posterior reversible encephalopathy syndrome.
Lamy C; Oppenheim C; Mas JL
Handb Clin Neurol; 2014; 121():1687-701. PubMed ID: 24365441
[TBL] [Abstract][Full Text] [Related]
15. Posterior reversible encephalopathy syndrome in a patient with mixed connective tissue disease: a case report.
Rahmanzadeh R; Rahmanzade R; Zabihiyeganeh M
J Med Case Rep; 2016 Jun; 10(1):145. PubMed ID: 27250498
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging features in posterior reversible encephalopathy syndrome: A pictorial review.
Ollivier M; Bertrand A; Clarençon F; Gerber S; Deltour S; Domont F; Trunet S; Dormont D; Leclercq D
J Neurol Sci; 2017 Feb; 373():188-200. PubMed ID: 28131186
[TBL] [Abstract][Full Text] [Related]
17. Posterior Reversible Encephalopathy Syndrome.
Gewirtz AN; Gao V; Parauda SC; Robbins MS
Curr Pain Headache Rep; 2021 Feb; 25(3):19. PubMed ID: 33630183
[TBL] [Abstract][Full Text] [Related]
18. Focal segmental glomerulosclerosis in children complicated by posterior reversible encephalopathy syndrome.
Stârcea M; Gavrilovici C; Munteanu M; Miron I
J Int Med Res; 2018 Mar; 46(3):1172-1177. PubMed ID: 29310486
[TBL] [Abstract][Full Text] [Related]
19. Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
Chelis L; Souftas V; Amarantidis K; Xenidis N; Chamalidou E; Dimopoulos P; Michailidis P; Christakidis E; Prassopoulos P; Kakolyris S
BMC Cancer; 2012 Oct; 12():489. PubMed ID: 23088634
[TBL] [Abstract][Full Text] [Related]
20. Pazopanib induced unilateral posterior reversible encephalopathy syndrome.
Arslan BM; Bajrami A; Demir E; Cabalar M; Yayla V
Ideggyogy Sz; 2017 Mar; 70(3-4):140-144. PubMed ID: 29870619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
